Literature DB >> 1243913

High incidence of chronic lymphocytic thyroiditis in apparently healthy school children: epidemiological and clinical study.

M Inoue, N Taketani, T Sato, H Nakajima.   

Abstract

An epidemiological survey on the incidence of juvenile chronic lymphocytic thyroiditis was performed in 10,220 apparently healthy school children in Ishikawa district, Japan. The subject of present study included 6,244 school children (2,831 boys and 3,413 girls, ages 6-18 yrs.) in Kanazawa City and 3,976 children (2,055 boys and 1,921 girls, ages 6-18 yrs.) in Wajima City. The first group was selected as a representative of urban area and the second group as that of seaside area. Children who have goiter or firm thyroid were selected for testing antithyroglobulin and anti-microsomal antibodies in sera. Final diagnosis of chronic lymphocytic thyroiditis was made on histological specimen obtained by needle biopsy on the antibody positive subjects. The overall incidence of chronic lymphocytic thyroiditis in these children was 3.0 per 1,000, whereas the incidence in adolescent girls was as high as 8.2 per 1,000. There was a considerable sex difference in the prevalence, the ratio of female to male was 6.5:1, and the incidence increased with age. The incidence in seaside area was 5.3 per 1,000 that was significantly higher than in urban area, 1.4 per 1,000 (p less than 0.005). Histologically, 26 of 30 cases (87%) were classified as focal thyroiditis and 4 cases (13%) were diffuse thyroiditis. Serum T4-I and T3 values within normal range in all patients, but resting TSH was elevated in 1 of 23 cases and TSH response to TRH was exaggerated in 3 of 23 cases. Impaired organification of iodide was observed in 6 of 32 cases by iodide-perchlorate discharge test. The present study demonstrates that juvenile chronic lymphocytic thyroiditis is highly prevalent among apparently healthy school children and early recognition of the disease with preventive care for hypothyroidism in future should be stressed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1243913     DOI: 10.1507/endocrj1954.22.483

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  8 in total

1.  Celiac disease in children and adolescents with Hashimoto Thyroiditis.

Authors:  Hale Tuhan; Sakine Işık; Ayhan Abacı; Erdem Şimşek; Ahmet Anık; Özden Anal; Ece Böber
Journal:  Turk Pediatri Ars       Date:  2016-06-01

2.  Thyroid diseases in a school population with thyromegaly.

Authors:  J Jaksić; M Dumić; B Filipović; J Ille; M Cvijetić; G Gjurić
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

3.  Iodized oil treatment for endemic goiter does not induce the surge of positive serum concentrations of anti-thyroglobulin or anti-microsomal autoantibodies.

Authors:  M Knobel; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

4.  Comparison of atrophic and goitrous auto-immune thyroiditis in children: clinical, laboratory and TSH-receptor antibody studies.

Authors:  N Matsuura; J Konishi; K Yuri; S Harada; K Fujieda; Y Nohara; Y Mikami; K Kasagi; Y Iida; A Hosoda
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

5.  Cells infiltrating the thyroid in juvenile autoimmune thyroiditis.

Authors:  S Kontiainen; I Lautenschlager; M Nyberg; J Mäenpää
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

Review 6.  Iodine, Seaweed, and the Thyroid.

Authors:  Peter P A Smyth
Journal:  Eur Thyroid J       Date:  2021-01-27

7.  Surgical treatment of multinodular goiter in young patients.

Authors:  Antonio Ríos; José M Rodríguez; Pedro J Galindo; Mariano J Montoya; Manuel Canteras; Pascual Parrilla
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

8.  Pericardial Effusion as a Presenting Symptom of Hashimoto Thyroiditis: A Case Report.

Authors:  Alberto Leonardi; Laura Penta; Marta Cofini; Lucia Lanciotti; Nicola Principi; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2017-12-14       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.